When Advanced Research Projects Agency for Health (ARPA-H) canceled Proposer's day for the #RareDisease AI/ML for Precision Integrated Diagnostics (#RAPID) program, the community came together anyway. This impromptu gathering was more than just a discussion of funding opportunities; it became a powerful example of how shared commitment to improving patient outcomes can transcend institutional boundaries and administrative hurdles. In anticipation of #RareDiseaseDay, please consider how you can contribute to #SystemsThinking to overcome critical bottlenecks in Rare Disease Care and Research. https://lnkd.in/gctbANM9
Nurture Genomics
医院和医疗保健
Cambridge，MA 1,941 位关注者
Nurture Genomics is how proactive parents and physicians uncover hidden, actionable health risks.
关于我们
We bridge the gap between knowledge and impact, providing parents and healthcare providers meaningful health insights based on cutting-edge genomic science. Led by clinical geneticists, researchers, and genetic counselors, Nurture puts genomic science into practice. We provide genome sequencing for healthy babies and children, facilitating early diagnosis and timely access to life-changing medical interventions.
- 网站
-
https://www.nurturegenomics.com/
Nurture Genomics的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 2-10 人
- 总部
- Cambridge，MA
- 类型
- 私人持股
地点
-
主要
获取路线
US，MA，Cambridge，02142
Nurture Genomics员工
动态
-
It was such a pleasure to meet James Cummings and 83 others from the rare disease community—individuals who won’t let anything stand in the way of progress. The passion and perseverance I saw in San Francisco is a powerful reminder that real change happens when we come together with a shared purpose. #RareDisease #Hinckley Nicholas Tatonetti, Robert Green MD, MPH, Terry Myerson, Melissa Haendel https://lnkd.in/eDAQXax5
-
The FDA has approved Crinecerfont, the first oral treatment for classic congenital adrenal hyperplasia (CAH), one of 413 treatable conditions on our panel. A major step forward for patients and families! #genomics #screening #treatment #progress https://lnkd.in/ekH46JKS
-
See how simple Nurture Genomics makes it to get started ?? – just a quick cheek swab at home ?? to screen for often hidden but treatable health risks. Stay tuned for part 2, where we'll share the personalized insights from the results ??? #ProactiveParenting #GenomicInsights #HappyBirthday https://lnkd.in/e4yhNact
-
A personal shoutout to Happiest Baby (the maker of SNOO) for featuring Nurture Genomics and our innovative approach to transforming pediatric healthcare! ? Their latest blog post includes an insightful interview with our Pediatric Medical Director, Molly OShea, MD, FAAP, who brings 30 years of expertise to the conversation on proactive health management. ???????? Check out the blog to learn more! ???? https://lnkd.in/ejbGaTYK #Genomics #PediatricHealth #ProactiveCare #HealthcareInnovation #Snoo #SmartSleeper
-
?? Nurture Genomics CEO Hans Keil recently participated in a panel discussing the future of newborn sequencing. The panel highlighted multiple paths to making genomic screening for treatable conditions available to children, focusing on balancing innovation with accessibility and healthcare equity. Explore how the International Consortium on Newborn Sequencing (ICoNS) is bringing the leaders in newborn sequencing together to end the diagnostic odyssey in pediatrics.
At 2:00 PM—2:30 PM, we will engage in a Private/Public Debate on the future of newborn sequencing, moderated by Dr. Stephen Kingsmore from BeginNGS. This panel will bring together leaders from both the public and private sectors, including Dr. Walter Kowtoniuk (Third Rock Ventures), Hans Keil (Nurture Genomics), Amy Gaviglio (CDC), and Dr. Jeff Brosco (HRSA), to explore the future landscape of newborn genomic screening. The discussion will examine the dynamics of public and private partnerships, debating their roles in shaping the evolution of NBSeq technologies and policies. With perspectives from venture capital, genomics companies, public health, and government, the panel will touch on key questions such as: How do we balance innovation with accessibility? What are the implications for healthcare equity and infrastructure? And how can we create sustainable models that benefit both the industry and public health? This debate promises to offer a thought-provoking view of what the future may hold for newborn sequencing, tackling essential issues that will define the next era of genomic medicine. Join us to hear from some of the top voices shaping this vital discussion! #ICoNS2024 #NBSeq #PublicPrivateDebate #FutureOfHealthcare
-
-
The results of the BabySeq Project counter the narrative that genetic testing is less useful or accurate for non-White individuals. Once more, it demonstrates the potential for genomic screening to prevent diagnostic odysseys and enable timely interventions, which could significantly improve outcomes for children at risk of genetic disorders. Overall, the data supports the broader applicability and utility of newborn sequencing across diverse populations, which will drive wider adoption and potentially influence policy decisions regarding the implementation of such screening programs. Also, this study reinforces the potential of companies working in this space, like Nurture Genomics. ??Robert Green MD, MPH https://lnkd.in/eZm3JRaj
-
-
Niemann-Pick Type C is another condition screened by Nurture Genomics. A new treatment approved by the FDA promises to bring hope to families affected by this rare disease. ?? The incredible pace of new treatments underscores the importance of early detection—proactive health has never been more vital. https://lnkd.in/eKGrKYtj #ProactiveHealth #Genomics #EarlyDetection #MedicalBreakthrough #RareDisease #NurtureGenomics #HealthcareInnovation
-
?? Nurture Genomics screens for 413 genetic variations linked to treatable diseases. One of those conditions is featured in this CBC article about Cardiac Ryanodine Receptor Calcium Release Deficiency Syndrome (CRDS)—a condition that can cause sudden cardiac arrest but is manageable when caught early. #genetichealth #earlydetection #CRDS ??https://lnkd.in/gnq3Hcxq
-
Attended an inspiring talk by Steve Kraus at Boston Health Innovation Night. ?? He shared how AI is pushing digital health to the front of the tech curve, allowing the sector to lead rather than catch up. Exciting times ahead for health tech! ?? #AI #HealthTech #Innovation #DigitalHealth #BessemerVenture Steven Wardell, Ethan Berg
-